Certified by Founder Lodge
Geneos Therapeutics
United States - Plymouth Meeting, PA
START UP
1 Disclosed Funding Rounds $5,000,000
0 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
At Geneos, our passion is to develop personalized therapies to unleash the most powerful force against cancer – your body’s own immune system. Our GT-EPIC Platform is designed to identify rel
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| April, 13 ,2023 | Series A | $5,000,000 | |
| September, 28 ,2023 | Series A | $5,000,000.00 |
3B Future Health Fund I & II
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Adronite | $5,000,000 | (Feb 20, 2026)
SPRX | $31,000,000 | (Feb 20, 2026)
Vizzia | $35,300,400 | (Feb 20, 2026)
Altesa BioSciences, Inc. | $75,000,000 | (Feb 20, 2026)
NuCube Energy | $13,000,000 | (Feb 20, 2026)
